home > drugs a-z list > synagis (palivizumab) drug center > synagis (palivizumab) drug - overdosage and contraindications

Recommended Topic Related To:

Synagis

Respiratory syncytial virus (RSV) facts

  • RSV is a highly contagious virus infection that most commonly causes illness during the winter season.
  • Most children who develop an RSV infection have mild symptoms of fever, nasal congestion, and nasal discharge.
  • High-risk groups are more likely to have a more severe disease process, including wheezing (bronchiolitis in infants) and/or pneumonia. Such high-risk groups include premature infants, those children with a compromised immune system, or those with chronic pulmonary disease or congenital/acquired cardiac disease.
  • Supportive care is the mainstay of therapy. For high-risk patients, palivizumab (Synagis) preventative therapy is available.

What is the respiratory syncytial virus (RSV)?

The respiratory syncytial virus (RSV), discovered in 1956, is capable of causing a broad spectrum of illnesses. Older children and adults will commonly e...

Synagis

font size

OVERDOSE

Overdoses with doses up to 70 mg per kg have been reported in clinical studies and post-marketing experience with Synagis, and in some cases, adverse reactions were reported. In case of overdosage, it is recommended that the patient be monitored for any signs or symptoms of adverse reactions and appropriate symptomatic treatment instituted.

CONTRAINDICATIONS

Synagis is contraindicated in children who have had a previous significant hypersensitivity reaction to Synagis [see WARNINGS AND PRECAUTIONS].

Last reviewed on RxList: 4/17/2012
This monograph has been modified to include the generic and brand name in many instances.

Synagis - User Reviews

Synagis User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Synagis sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.